Gilead Sciences, Inc.
—- Market cap
- $179.56B
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
GILD · price snapshotP/E 21.36x
$144.81Snapshot Sep 10, 2026, 4:00 PM ET
Implied fair value · at AMGN's multiple
$182.2325.8% above market
6.78 GILD Annual EPS×26.88x AMGN P/E=$182.23
Market $144.81Implied $182.23
AMGN · price snapshotP/E 26.88x
$382.47Snapshot Sep 10, 2026, 4:00 PM ET
Implied fair value · at GILD's multiple
$303.9320.5% below market
14.23 AMGN Annual EPS×21.36x GILD P/E=$303.93
Market $382.47Implied $303.93